PROCEPT BioRobotics Corporation (PRCT)
NASDAQ: PRCT · Real-Time Price · USD
58.64
-1.42 (-2.36%)
At close: Jul 24, 2025, 4:00 PM
59.39
+0.75 (1.28%)
After-hours: Jul 24, 2025, 7:32 PM EDT
Company Description
PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally.
The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia.
It also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia.
PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
PROCEPT BioRobotics Corporation
| Country | United States |
| Founded | 2009 |
| IPO Date | Sep 15, 2021 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 756 |
| CEO | Reza Zadno |
Contact Details
Address: 150 Baytech Drive San Jose, California 95134 United States | |
| Phone | 650 232 7200 |
| Website | procept-biorobotics.com |
Stock Details
| Ticker Symbol | PRCT |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $25.00 |
| CIK Code | 0001588978 |
| CUSIP Number | 74276L105 |
| ISIN Number | US74276L1052 |
| Employer ID | 26-0199180 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Dr. Reza Zadno Ph.D. | President, Chief Executive Officer and Director |
| Kevin Waters | Executive Vice President and Chief Financial Officer |
| Alaleh Nouri | EVice President, Chief Legal Officer and Corporate Secretary |
| Hisham Shiblaq | Executive Vice President and Chief Commercial Officer |
| Christofer Christoforou | Senior Vice President of Operations |
| Barry Templin | Executive Vice President of Technology and Clinical Development |
| Matthew James Bacso C.F.A. | Vice President of Investor Relations |
| Stacey L. Porter | Chief People Officer |
| Bijesh Chandran | Senior Vice President of Regulatory Affairs and Quality Assurance |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 11, 2025 | 8-K | Current Report |
| Jun 6, 2025 | 144 | Filing |
| Jun 3, 2025 | 144 | Filing |
| May 30, 2025 | SD | Form - SD |
| May 2, 2025 | 10-Q | Quarterly Report |
| Apr 25, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 25, 2025 | DEF 14A | Other definitive proxy statements |
| Apr 25, 2025 | 8-K | Current Report |
| Apr 24, 2025 | 8-K | Current Report |
| Apr 11, 2025 | 10-K/A | [Amend] Annual report |